| Products |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
| Cell Signaling Pathway Inhibitors |
Now Position:Home > Products > Cell Signaling Pathway Inhibitors < Inhibitors of MAPK/ERK pathway |
|
| Trametinib; JTP-74057; GSK1120212(CAS:871700-17-3, 871702-06-6 (sodium salt)) |
 |
|
|
Product No.
|
|
TP1110A
|
|
Name
|
|
Trametinib
|
|
Synonyms
|
|
JTP-74057; GSK1120212
|
|
CAS Number
|
|
871700-17-3, 871702-06-6 (sodium salt)
|
|
Structure
|
|
|
|
Brief Description
|
|
Trametinib, (GSK1120212, JTP-74057) is a highly specific and potent MEK1 and MEK2 inhibitor with IC50 of 0.92 nM and 1.8 nM, respectively.
|
|
Purity
|
|
>99%
|
|
Package
|
|
5mg，10mg，20mg，50mg
|
|
|
|
|
|
|
